Shamrock Industrial Company
- Market cap
- ₹ 15 Cr.
- P/B
- 28.68x
- ROE
- −102%
- ROCE
- −102.4%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Commercial Services & Supplies
- Industry
- Trading & Distributors
- Listed on
- BSE
About
Shamrock Industrial Company Limited is an India-based pharmaceuticals company. The Company offers a diverse range of manufacturing of pharmaceuticals and drugs products and allied business activities. It offers its products for various therapeutic uses, including anti-coagulants (anti-platelet), radio-protective agents, platelet regulator, anti-depressants, anti-neo plastics and immunosuppressants, antihistamines, sympathomimetics, anti-hypertensives, diuretic, anti-diabetic, calcium regulating agents, local anesthetics and anti-bacterial. Its active pharmaceutical ingredient (API) product list (manufactured) includes acenocomarol, amifostine, ciclopirox, cilazapril, losartan potassium, metaxalone, metoprolol succinate and pregabalin. The Company's API product list (contract manufactured) includes abacavir, acarbose, oxaliplatin, oxaprozin, finasteride, frusemide and colchicine.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Trading & Distributors: 197 companies →Shamrock Industrial Company against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Size₹ 14.8 Cr. market value against a typical ₹ 26.8 Cr. (1st = largest).120th of 183
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Operating Profit | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −1 | −0 | −0 |
| OPM % | 81.8% | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −1 | −0 | −0 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −1 | −0 | −0 |
| EPS in Rs | 0.17 | −0.09 | −0.04 | −0.11 | −0.04 | −0.04 | −0.06 | −0.22 | −0.59 | −1.01 | −0.18 | −0.18 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- 4%
- 5 Years
- —
- 3 Years
- —
- TTM
- −463%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 84%
- TTM
- —
- 10 Years
- −27%
- 5 Years
- −19%
- 3 Years
- −28%
- TTM
- —
Peers
Listed companies in the same business.
| Shamrock Industrial Company | — | ₹ 15 Cr. | — | 28.7x | −102% | — |
| Sun Pharmaceutical Industries | ₹ 1,743.00 | ₹ 4,18,194 Cr. | 37.7x | 5.5x | — | 19.8% |
| Divi's Laboratories | ₹ 8,984.00 | ₹ 2,38,497 Cr. | 91.3x | 14.3x | — | 26.1% |
| Torrent Pharmaceuticals | ₹ 4,482.00 | ₹ 1,70,475 Cr. | 74.7x | 19.7x | — | 13.7% |
| Cipla | ₹ 1,337.00 | ₹ 1,08,011 Cr. | 27.3x | 3.3x | — | 11.9% |
| Laurus Labs | ₹ 1,974.00 | ₹ 1,08,738 Cr. | 114.1x | 19.2x | — | 15% |
Management
- Rattan Kapoor
- Chief Executive Officer, Managing Director, Additional Executive Director
- Rahul Manoj Rajani
- Chief Financial Officer, Whole Time Director
- Bagepalli Vijayakumar Harish
- Chief Operating Officer, Additional Executive Director
- Khushboo Gulati
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.